Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
336. |
ECCT/18/04/01 | CKAF156 STUDY A Phase 2 interventional, multicenter, randomized open-label study to determine the effective and tolerable dose of KAF156 and Lumefantrine Solid Dispersion Formulation in combination, given once daily for 1, 2 and 3-days to adults and children with uncomplicated Plasmodium falciparum malaria. |
Principal Investigator(s) 1. Bernhards Ogutu Site(s) in Kenya 1. KEMRI CDC (Siaya county) 2. Walter Reed Project (Kisumu county) |
View |
337. |
ECCT/18/03/01 | JiPime JiPrEP (HIVST Study) HIV self-testing to improve the efficiency of PrEP delivery. |
Principal Investigator(s) 1. Kenneth Kairu Ngure Site(s) in Kenya KEMRI-CCR PHRD (THIKA) |
View |
338. |
ECCT/18/01/01 | Mal 094 Efficacy, safety and immunogenicity study of GSK Biologicals’ candidate malaria vaccine (SB257049) evaluating schedules with or without fractional doses, early Dose 4 and yearly doses, in children 5-17 months of age. |
Principal Investigator(s) 1. Aaron Samuels 2. Simon Kariuki Site(s) in Kenya 1. Siaya County Referral hospital (Siaya county) 2. Ngiya Health Center (Siaya county) 3. Kogelo Health Center (Siaya county) 4. Tingwangi (Siaya county) 5. Mulaha (Siaya county) 6. Nyathengo (Siaya county) 7. Bal Olengo (Siaya county) |
View |
339. |
ECCT/17/11/01 | MTN 034 MTN 034 A Phase 2a Crossover Trial Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female Population |
Principal Investigator(s) 1. ESTHER MUMBI MAKANGA Site(s) in Kenya KISUMU CRS |
View |
340. |
ECCT/17/10/01 | Neo-Fosfo Intravenous and Oral Fosfomycin in Hospitalised Neonates with Clinical Sepsis: an open-label safety and pharmacokinetics study |
Principal Investigator(s) 1. James A Berkley Site(s) in Kenya KEMRI-WTRP |
View |